Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemiaYajnavalka Banerjee, Manfredi Rizzo, Anca Pantea Stoian et al.|Expert Opinion on Drug Safety|2021Cited by 53
Diabetic Cardiomyopathy: 2023 Update by the International Multidisciplinary Board of ExpertsAshot Avagimyan, Nizal Sarrafzadegan, Е А Коган et al.|Current Problems in Cardiology|2023Cited by 42